14:58 , May 30, 2019 |  BioCentury  |  Emerging Company Profile

Thrive’s quest to bring multicancer liquid biopsy test into routine clinical use

With Third Rock leading the way in a $110 million series A, newly launched Thrive is banking that a multi-analyte approach to liquid biopsy could give it an edge in creating a test that is...
19:42 , May 6, 2019 |  BC Extra  |  Financial News

May 6 Financial Quick Takes: Athenex, Spiral

Athenex raises $100M to advance Oraxol  Looking to fund commercialization activities for Oraxol and advance its oncology pipeline and actinic keratosis therapy, Athenex Inc. (NASDAQ:ATNX) raised $100 million in a private placement through the sale...
18:36 , Jun 22, 2018 |  BC Week In Review  |  Financial News

Qiming leads series B for cancer play WindMIL

WindMIL Therapeutics Inc. (Baltimore, Md.) raised $32.5 million on June 18 in an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners Nexus and the Kinneret Group participated...
22:20 , Jun 18, 2018 |  BC Extra  |  Financial News

Qiming leads series B for cancer play WindMIL

WindMIL Therapeutics Inc. (Baltimore, Md.) raised $32.5 million in an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners Nexus and the Kinneret Group participated alongside existing investors...
07:00 , Aug 11, 2016 |  BC Extra  |  Financial News

Metabolon raises $15M in series E

Metabolon Inc. (Durham, N.C.) raised a $15 million series E round. Metabolon said the round's sole investor, Essex Woodlands, may invest an additional $10 million, which Metabolon would use to buy back shares from existing...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

Metabolon board of directors update

Metabolon Inc. , Durham, N.C.   Business: Supply/Service, Diagnostic   Appointed: Christopher Kersey, managing member at Camden Partners  ...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

Metabolon completes venture financing

Metabolon Inc. , Durham, N.C.   Business: Supply/Service, Diagnostic   Date completed: 1/3/14   Type: Venture financing   Raised: $15 million   Investors: Camden Partners; Sumitomo; Aurora Funds; Harris & Harris Group; Syngenta; Fletcher Spaght...
00:53 , Jan 4, 2014 |  BC Extra  |  Financial News

Metabolon raises $15 million in E round

Metabolomics company Metabolon Inc. (Durham, N.C.) raised $15 million in a series E round led by new investor Camden Partners. New investor Sumitomo Corp. (Tokyo:8053) also participated, along with existing investors Aurora Funds; Harris &...
07:00 , Jun 27, 2011 |  BioCentury  |  Finance

What to do with $101M

Last week's $101M tranched series B round for oncology play Tesaro Inc. is expected to get the company to NDA submission for its lead candidate, in-license up to two additional compounds and advance a preclinical...
07:00 , Jun 27, 2011 |  BioCentury  |  Finance

Particle math

Particle math Cardiovascular diagnostic company LipoScience Inc. filed late last week to raise up to $86.3 million in an IPO on NASDAQ. The company has raised $58.7 million in venture capital and was cash flow...